Payer coverage information for select RA patients. Learn more about national payer coverage information for treatment of this condition. In...
Information and resources for patients considering an autoinjector to manage the symptoms of rheumatoid arthritis (RA) Information and resources for...
The National Association for Medication Access and Patient Advocacy (NAMAPA) has launched the Medication Access Coordinator Training with the aim...
The Change Healthcare cyber attack has been a big problem for the industry. NORM conducted a survey with our memebrship...
Per the CMS press release: Overall, the finalized CY 2024 PFS conversion factor is $32.74, a decrease of $.1.15, or 3.4%, from CY...
The United States Senate Committee of Finance released their report titled "Deceptive Marketing Practices Flourish in Medicare Advantage" and excerpts from...
PAYER BARRIERS LIMIT TIMELY ACCESS Authored by Aurinia Pharma U.S., Inc. Timely access to therapy can be difficult to achieve....
The SAPHNELO Policy Acumen Portal provides up-to-date resources for billing, coding, and coverage policies specific to preselected payers. The link...
Deciding to start a blog comes with many questions and requires a lot of thought. During this process, one of...
Access Full Article from Reuters - Here
UPDATE! New Permanent J Code for SAPHNELO (anifrolumab-fnia) injection, for intravenous use, 300 mg/2mL The Centers for Medicare and Medicaid...
Wait times are a small part of each patient’s overall experience but can be a significant concern the longer they...